Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / patent

patent

Scientists developed coral-inspired material to revolutionize bone repair
Biotechnology | Marine Science | Materials | Therapeutics

Scientists developed coral-inspired material to revolutionize bone repair

On Dec. 3, 2024, researchers at Swansea University in Wales announced they have developed a revolutionary bone graft…

Read More Scientists developed coral-inspired material to revolutionize bone repairContinue

Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving
Biotechnology | Diagnostics | Medical Device

Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving

On Oct. 16, 2024, Know Labs in Seattle announced that it had retained The Stanbridge Group to secure…

Read More Know Labs Sensor Technology in Steering Wheels Could Curb Impaired DrivingContinue

Adaptive 3D printing system to pick and place bugs and other organisms
Biotechnology | Diagnostics | Non-Profit Research

Adaptive 3D printing system to pick and place bugs and other organisms

On Aug. 21, 2024, researchers at the University of Minnesota (UM) announced a first-of-its-kind adaptive 3D printing system…

Read More Adaptive 3D printing system to pick and place bugs and other organismsContinue

BioNTech sued by UPenn over COVID-19 vaccine patent royalties
Biotechnology | COVID-19 | Infectious Disease | Vaccine

BioNTech sued by UPenn over COVID-19 vaccine patent royalties

On Aug. 6, 2024, the University of Pennsylvania announced it had sued German biotechnology firm BioNTech n Pennsylvania…

Read More BioNTech sued by UPenn over COVID-19 vaccine patent royaltiesContinue

Smart phone Invention Revolutionizes Ability To Detect Harmful Chemicals
Chemical | Diagnostics

Smart phone Invention Revolutionizes Ability To Detect Harmful Chemicals

On Jul. 16, 2024, Texas A&M University scientists announced receipt of a patent for a hand-held cellphone-based Raman…

Read More Smart phone Invention Revolutionizes Ability To Detect Harmful ChemicalsContinue

USDA researchers used edible blue-green algae to protect honey bees against viruses
Agriculture | Life Science History | USDA

USDA researchers used edible blue-green algae to protect honey bees against viruses

On Mar. 19, 2024, scientists at the United States Department of Agriculture (USDA)メs Agricultural Research Service (ARS) announced…

Read More USDA researchers used edible blue-green algae to protect honey bees against virusesContinue

The Priestley Medal was awarded to Cato T. Laurencin
Biotechnology | Chemical | Materials | Nanotechnology

The Priestley Medal was awarded to Cato T. Laurencin

On Mar. 28, 2023, the American Chemical Society awarded The Priestley Medal to Cato T. Laurencin “to recognize distinguished…

Read More The Priestley Medal was awarded to Cato T. LaurencinContinue

Moderna to make milestone payments to NIH for COVID vaccine
Biotechnology | COVID-19 | Infectious Disease | NIH | Vaccine

Moderna to make milestone payments to NIH for COVID vaccine

On Feb. 24, 2023, Moderna announced will make certain contingent development, commercial and regulatory milestone payments to the…

Read More Moderna to make milestone payments to NIH for COVID vaccineContinue

Purdue Center for Cancer Research renamed Purdue Institute for Cancer Research
Biotechnology | Diagnostics | Oncology | Therapeutics

Purdue Center for Cancer Research renamed Purdue Institute for Cancer Research

On Jan. 6, 2023, the Purdue Center for Cancer Research announced it was changing its name to the…

Read More Purdue Center for Cancer Research renamed Purdue Institute for Cancer ResearchContinue

U.S. patent appeal board ruled against University of California in CRISPR interference
Biotechnology | CRISPR | Disease | Genomics | Therapeutics

U.S. patent appeal board ruled against University of California in CRISPR interference

On Feb. 28, 2022, the Patent and Trial Appeal Board of the U.S. Patent and Trademark Office (USPTO)…

Read More U.S. patent appeal board ruled against University of California in CRISPR interferenceContinue

Evolution of CRISPR
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Life Science History | Therapeutics

Evolution of CRISPR

The Evolution of CRISPR illustrates its climb out of the primordial ocean on the backs of eukaryotic cells…

Read More Evolution of CRISPRContinue

Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies
Life Science History | Nanotechnology

Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies

On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…

Read More Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic IntensifiesContinue

The Medicines Patent Pool secured its first licence for malaria, tuberculosis and hepatitis C
Life Science History | Nanotechnology

The Medicines Patent Pool secured its first licence for malaria, tuberculosis and hepatitis C

On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…

Read More The Medicines Patent Pool secured its first licence for malaria, tuberculosis and hepatitis CContinue

Novavax initiated phase 1/2 clinical trial of combination vaccine for COVID-19 and seasonal influenza
Biotechnology | COVID-19 | Infectious Disease | Influenza | Vaccine

Novavax initiated phase 1/2 clinical trial of combination vaccine for COVID-19 and seasonal influenza

On Sept. 8, 2021, Novavax announced enrollment of the first participants in a Phase 1/2 study to evaluate…

Read More Novavax initiated phase 1/2 clinical trial of combination vaccine for COVID-19 and seasonal influenzaContinue

Novavax and EC finalized advance purchase agreement for up to 200 million doses of COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax and EC finalized advance purchase agreement for up to 200 million doses of COVID-19 vaccine

On Aug. 4, 2021, Novavax announced that it had reached an agreement with the European Commission (EC) for…

Read More Novavax and EC finalized advance purchase agreement for up to 200 million doses of COVID-19 vaccineContinue

Celsion filed provisional U.S. patent application for broad range of next generation DNA vaccines
Biotechnology | Nanotechnology | Vaccine

Celsion filed provisional U.S. patent application for broad range of next generation DNA vaccines

On Jan. 28, 2021, Celsion announced the filing of a provisional U.S. patent application for a novel DNA-based,…

Read More Celsion filed provisional U.S. patent application for broad range of next generation DNA vaccinesContinue

AXIM Biotechnologies completed successful Covid-19 live virus test and filed amended EUA
Biotechnology | COVID-19 | Diagnostics

AXIM Biotechnologies completed successful Covid-19 live virus test and filed amended EUA

On Dec. 15, 2020, AXIM Biotechnologies announced the development and patent filing for an enzyme-linked immunosorbent assay (ELISA)-based…

Read More AXIM Biotechnologies completed successful Covid-19 live virus test and filed amended EUAContinue

AXIM Biotechnologies filed patent for virus binding recombinant protein for SARS-CoV-2 and began manufacturing
Biotechnology | COVID-19 | Diagnostics

AXIM Biotechnologies filed patent for virus binding recombinant protein for SARS-CoV-2 and began manufacturing

On Dec. 3, 2020, AXIM Biotechnologies announced the development and patent filing for an enzyme-linked immunosorbent assay (ELISA)-based…

Read More AXIM Biotechnologies filed patent for virus binding recombinant protein for SARS-CoV-2 and began manufacturingContinue

Viatris announced FDA tentative approval of pediatric formulation of Dolutegravir under PEPFAR
FDA | HIV | Life Science History

Viatris announced FDA tentative approval of pediatric formulation of Dolutegravir under PEPFAR

On Nov. 23, 2020, Viatris announced tentative approval from the FDA for a New Drug Application for pediatric…

Read More Viatris announced FDA tentative approval of pediatric formulation of Dolutegravir under PEPFARContinue

AXIM Biotechnologies filed patent for world’s first face mask designed to capture SARS-CoV-2 COVID-19
COVID-19 | Medical Device | Therapeutics

AXIM Biotechnologies filed patent for world’s first face mask designed to capture SARS-CoV-2 COVID-19

On Sept. 29, 2020, AXIM Biotechnologies announced that it had filed a provisional patent for a first-in-class face…

Read More AXIM Biotechnologies filed patent for world’s first face mask designed to capture SARS-CoV-2 COVID-19Continue

AXIM Biotechnologies applied for FDA Emergency Use Approval for high throughput, neutralizing antibody diagnostic test for COVID-19
Biotechnology | COVID-19 | Diagnostics

AXIM Biotechnologies applied for FDA Emergency Use Approval for high throughput, neutralizing antibody diagnostic test for COVID-19

On Aug. 5, 2020, AXIM Biotechnologies announced the development, patent filing and Emergency Use Approval (EUA) filing of…

Read More AXIM Biotechnologies applied for FDA Emergency Use Approval for high throughput, neutralizing antibody diagnostic test for COVID-19Continue

UConn-made COVID-19 custom mask solution to be manufactured
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

UConn-made COVID-19 custom mask solution to be manufactured

On Jul. 2, 2020, UConn announced a licensing deal with Connecticut Biotech, a startup company headquartered in South…

Read More UConn-made COVID-19 custom mask solution to be manufacturedContinue

AIM ImmunoTech filed provisional patent application for ose of Ampligen(R) as potential therapy for COVID-19 Induced chronic fatigue
COVID-19 | Life Science History

AIM ImmunoTech filed provisional patent application for ose of Ampligen(R) as potential therapy for COVID-19 Induced chronic fatigue

On Jun. 11, 2020, AIM ImmunoTech announced that it had filed a provisional patent application for, among other…

Read More AIM ImmunoTech filed provisional patent application for ose of Ampligen(R) as potential therapy for COVID-19 Induced chronic fatigueContinue

iBio announced second COVID-19 vaccine program
COVID-19 | Life Science History | Vaccine

iBio announced second COVID-19 vaccine program

On Jun. 4, 2020, iBio announced it had initiatied preclinical immunization studies for its second COVID-19 vaccine platform….

Read More iBio announced second COVID-19 vaccine programContinue

Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead program
COVID-19 | Life Science History

Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead program

On May 13, 2020,Catalent announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at…

Read More Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead programContinue

USPTO announced COVID-19 Prioritized Examination Pilot Program for small and micro entities
COVID-19

USPTO announced COVID-19 Prioritized Examination Pilot Program for small and micro entities

On May 8, 2020, the U.S. Patent and Trademark Office (USPTO) announced a new COVID-19 Prioritized Examination Pilot…

Read More USPTO announced COVID-19 Prioritized Examination Pilot Program for small and micro entitiesContinue

Medigen Vaccine Biologics signed a license agreement with NIH on COVID-19 vaccine
COVID-19 | Life Science History | NIH | Vaccine

Medigen Vaccine Biologics signed a license agreement with NIH on COVID-19 vaccine

On May 5, 2020, Medigen Vaccine Biologics (MVB) announced a global commercial license agreement with National Institutes of…

Read More Medigen Vaccine Biologics signed a license agreement with NIH on COVID-19 vaccineContinue

USPTO launched platform to facilitate connections between patent holders and potential licensees in key technologies
Biotechnology | COVID-19 | Diagnostics | Medical Device | Non-Profit Research | Pharmaceutical | Therapeutics

USPTO launched platform to facilitate connections between patent holders and potential licensees in key technologies

On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…

Read More USPTO launched platform to facilitate connections between patent holders and potential licensees in key technologiesContinue

Cocrystal Pharma expanded exclusive license agreement with Kansas State University Research Foundation to new Coronavirus antiviral compound
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics

Cocrystal Pharma expanded exclusive license agreement with Kansas State University Research Foundation to new Coronavirus antiviral compound

On Apr. 22, 2020, Cocrystal Pharma announced it has expanded its previously announced license agreement with Kansas State…

Read More Cocrystal Pharma expanded exclusive license agreement with Kansas State University Research Foundation to new Coronavirus antiviral compoundContinue

New virus detection process under development at Rutgers-Camden
COVID-19 | Life Science History

New virus detection process under development at Rutgers-Camden

On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers UniversityヨCamden research laboratory, where chemistry…

Read More New virus detection process under development at Rutgers-CamdenContinue

Page navigation

1 2 3 4 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search